Alexandre Bélot
Université Claude Bernard Lyon 1(FR)École Normale Supérieure de Lyon(FR)Centre National de la Recherche Scientifique(FR)Inserm(FR)Lyon College(US)Université Paris-Saclay(FR)Hôpital Femme Mère Enfant(FR)CIRI Foundation(US)Communauté urbaine de Lyon(FR)Assistance Publique – Hôpitaux de Paris(FR)Centre de Référence des Maladies Autoinflammatoires et des Amyloses(FR)Hospices Civils de Lyon(FR)The Lymphoma Academic Research Organisation(FR)Immunology from Concept and Experiments to Translation(FR)Hôpital Pellegrin(FR)Hôpital Lyon Sud(FR)ERN GUARD-Heart(NL)Center for Rheumatology(US)Centre International de Recherche en Infectiologie(FR)Bicêtre Hospital(FR)
Publications by Year
Research Areas
Autoimmune and Inflammatory Disorders Research, Inflammasome and immune disorders, Systemic Lupus Erythematosus Research, Immunodeficiency and Autoimmune Disorders, Adolescent and Pediatric Healthcare
Most-Cited Works
- → Autoantibodies against type I IFNs in patients with life-threatening COVID-19(2020)2,815 cited
- → EULAR/PRINTO/PRES criteria for Henoch–Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria(2010)1,398 cited
- → Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions(2020)690 cited
- → Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths(2021)617 cited
- → Human genetic and immunological determinants of critical COVID-19 pneumonia(2022)384 cited
- → Detection of interferon alpha protein reveals differential levels and cellular sources in disease(2017)370 cited